877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, matrixscientific.com, Pharmaceuticals, Tetracyclic compounds, Cycloalkanes

Categories

Antineoplastic and immunomodulating drugs (1)
Antineoplastic drugs (1)
Cyclic compounds (1)
Cyclopropanes (1)
Experimental cancer drugs (1)
Halides (1)
Organofluorides (1)
Organohalides (1)
Piperazines (1)
Six-membered rings (1)
Three-membered rings (1)

Zosuquidar Trihydrochloride (167465-36-3)  
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
Related searches
Polycyclic organic compounds
matrixscientific.com
Pharmaceuticals
Tetracyclic compounds
Cycloalkanes